Abstract:Duchenne muscular dystrophy is a group of serious progressive hereditary myopathy, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Because DMD/BMD is an X-linked recessive hereditary disease, it is common in male, and DMD is the most. There is one patient in every 3 500-5 000 newborns in the world, most female carriers have a normal phenotype, and a few may have some symptoms. They are common diseases among rare diseases. It is a common disease among rare diseases. Improvements in child care and disease management have slowed the progression of the disease, but current treatment methods cannot prevent the relentless loss of muscle tissue and function, leading to premature death. This article reviews the progress of the treatment of DMD/BMD muscular dystrophy by consulting domestic and foreign literature.